factual
KJ Muldoon personalized base-editing treatment
KJ Muldoon, born with CPS1 deficiency that affects roughly 1 in 1.3 million children and causes toxic ammonia buildup, was treated at Children's Hospital of Philadelphia with a personalized mRNA-delivered base editor given in three doses, with FDA approval within weeks, and now no longer needs a liver transplant, though he is not cured.
factualpending
Speaker
Jeff CollerEvidence Quote
“KJ was born with an ultra-rare genetic condition that affects about 1 in 1.3 million children born... He doesn't need a liver transplant. He's not cured.”
Created: 11/17/2026, 7:10:08 AM
Your notes
Loading notes...